Alnylam Pharmaceuticals
ALNY
#566
Rank
A$59.25 B
Marketcap
A$446.76
Share price
-1.75%
Change (1 day)
16.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company